Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors

Published:2020-11-24 Issue:2 Volume:46 Page:111-118
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Thuillier Philippe,Maajem Meriem,Schick Ulrike,Blanc-Beguin Frédérique,Hennebicq Simon,Metges Jean-Philippe,Salaun Pierre-Yves,Kerlan Véronique,Bourhis David,Abgral Ronan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological, nuclear medicine & hybrid Imaging;Neuroendocrinology,2017

2. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors;N Engl J Med,2017

3. SUV of [68Ga]DOTATOC-PET/CT predicts response probability of PRRT in neuroendocrine tumors;Mol Imaging Biol,2015

4. 68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours;Radiother Oncol,2019

5. 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor–mediated radionuclide therapy;J Nucl Med,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy;Journal of Nuclear Medicine;2024-03

2. A radiomic‐ and dosiomic‐based machine learning regression model for pretreatment planning in ¹⁷⁷Lu‐DOTATATE therapy;Medical Physics;2023-09-18

3. Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling;EJNMMI Physics;2023-08-24

4. [18F] AlF-NOTA-FAPI-04 PET/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2023-06-17

5. Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE;Cancers;2023-02-10